Maryland Prescription Drug Affordability Board

​Announcements

• January 26, 2026 Prescription Drug Affordability Board Meeting CANCELED. Due to the declared state of emergency and the closing of State offices and facilities, the Prescription Drug Affordability Board meeting scheduled for Monday, January 26, 2026 is cancel​ed. When the meeting is rescheduled, the Board will provide advance notice of the rescheduled meeting date on the website and through the listserv.​

• Informational Hearing Notice: The Maryland Prescription Drug Affordability Board is evaluating its cost review study process (COMAR 14.01.04.01, et seq.) and policy review procedures (COMAR 14.01.05.01, et seq.), and invites public comment on these procedures. More information can be found here. These hearings will take place on February 10, 2026.
• Written Comment Request: 
  I​n accordance with COMAR 14.01.05.06A and 14.01.01.05B(4), the Prescription Drug Affordability Board requests public written comment on the revised framework documents for Ozempic and Trulicity. 
  Comments will be accepted through close of business February 17, 2026. More information can be found here​. ​
• Join the PDAB Mailing List here​.​